Illumina, Inc. (ILMN)
218.22
-3.44
(-1.55%)
USD |
NASDAQ |
Sep 04, 16:00
221.23
+3.01
(+1.38%)
After-Hours: 20:00
Illumina Research and Development Expense (Quarterly) : 257.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 257.00M |
| March 31, 2026 | 240.00M |
| December 31, 2025 | 238.00M |
| September 30, 2025 | 228.00M |
| June 30, 2025 | 243.00M |
| March 31, 2025 | 241.00M |
| December 31, 2024 | 255.00M |
| September 30, 2024 | 252.00M |
| June 30, 2024 | 325.00M |
| March 31, 2024 | 338.00M |
| December 31, 2023 | 329.00M |
| September 30, 2023 | 315.00M |
| June 30, 2023 | 358.00M |
| March 31, 2023 | 341.00M |
| December 31, 2022 | 339.00M |
| September 30, 2022 | 325.00M |
| June 30, 2022 | 327.00M |
| March 31, 2022 | 323.00M |
| December 31, 2021 | 350.00M |
| September 30, 2021 | 436.00M |
| June 30, 2021 | 202.00M |
| March 31, 2021 | 197.00M |
| December 31, 2020 | 200.00M |
| September 30, 2020 | 172.00M |
| June 30, 2020 | 155.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 156.00M |
| December 31, 2019 | 161.00M |
| September 30, 2019 | 151.00M |
| June 30, 2019 | 166.00M |
| March 31, 2019 | 169.00M |
| December 31, 2018 | 176.00M |
| September 30, 2018 | 159.00M |
| June 30, 2018 | 151.00M |
| March 31, 2018 | 137.00M |
| December 31, 2017 | 137.00M |
| September 30, 2017 | 134.00M |
| June 30, 2017 | 130.00M |
| March 31, 2017 | 140.00M |
| December 31, 2016 | 129.92M |
| September 30, 2016 | 125.92M |
| June 30, 2016 | 124.59M |
| March 31, 2016 | 123.99M |
| December 31, 2015 | 114.35M |
| September 30, 2015 | 99.23M |
| June 30, 2015 | 96.18M |
| March 31, 2015 | 91.77M |
| December 31, 2014 | 93.71M |
| September 30, 2014 | 84.59M |
| June 30, 2014 | 82.49M |
| March 31, 2014 | 76.96M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 364.00M |
| Agilent Technologies, Inc. | 120.00M |
| Danaher Corp. | 412.00M |
| Pacific Biosciences of California, Inc. | 23.02M |
| Bio-Rad Laboratories, Inc. | 61.20M |